|Articles|July 2, 2011

Pharmaceutical Technology

  • Pharmaceutical Technology-07-02-2011
  • Volume 35
  • Issue 7

Q&A with Steve Strickland, Sensient

Steve Strickland, general manager of Sensient Pharmaceutical Coating Systems, on recent industry trends.

Q&A with Steve Strickland, general manager of Sensient Pharmaceutical Coating Systems

PharmTech:

What is the biggest industry challenge you're now facing?

Strickland:

A major challenge is maintaining continuous scientific innovation to meet the product demands of our customers. We are constantly looking for opportunities to expand our technical expertise and service either through internal development or acquisition.

I think that the consolidation within the pharmaceutical industry we serve will continue to play a role in our growth. Consolidation often brings personnel change, accompanied by shifts in the direction of research and development. We need to evolve along with our customers based on their changing needs.

PharmTech:

How do you stay abreast of new developments in the industry?

Strickland:

Our primary method of staying on top of industry developments is listening to our customers. Also, trade shows and trade publications are an excellent source of emerging industry trends, and we'll continue to rely on them.

PharmTech:

Do you see a new industry trend emerging?

Strickland:

Yes, the trend toward globalization of our industry continues to gain momentum. For example, the emergence of global markets, the multinational presence of pharmaceutical companies, and the location of manufacturing sites around the world demand an increased knowledge of the accompanying regulatory requirements.

PharmTech:

What is the most common demand your clients are currently making of you?

Strickland:

They demand high product quality. In an industry that is constantly under scrutiny, our customers demand excellence in the quality and performance of our products.

Articles in this issue

over 15 years ago

FDA Introduces Spectral Library

over 15 years ago

Biotech Financing Blues

over 15 years ago

All the Wrong Questions

over 15 years ago

In the Spotlight July 2011

over 15 years ago

Pharma Leads in Sustainability

over 15 years ago

In Search of an Optimal Solid Form

over 15 years ago

Report from Europe

Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.